Hamada, S.; Matsumoto, R.; Tanaka, Y.; Taguchi, K.; Yamamoto, M.; Masamune, A.
Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition. Int. J. Mol. Sci. 2021, 22, 1870.
https://doi.org/10.3390/ijms22041870
AMA Style
Hamada S, Matsumoto R, Tanaka Y, Taguchi K, Yamamoto M, Masamune A.
Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition. International Journal of Molecular Sciences. 2021; 22(4):1870.
https://doi.org/10.3390/ijms22041870
Chicago/Turabian Style
Hamada, Shin, Ryotaro Matsumoto, Yu Tanaka, Keiko Taguchi, Masayuki Yamamoto, and Atsushi Masamune.
2021. "Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition" International Journal of Molecular Sciences 22, no. 4: 1870.
https://doi.org/10.3390/ijms22041870
APA Style
Hamada, S., Matsumoto, R., Tanaka, Y., Taguchi, K., Yamamoto, M., & Masamune, A.
(2021). Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition. International Journal of Molecular Sciences, 22(4), 1870.
https://doi.org/10.3390/ijms22041870